MorphoMed’s innovative lead product is a regenerative anterior cruciate ligament (RegACL) implant made from medical silk fibroin filaments, a first-in-class scaffold for natural tissue regeneration which grants full stability immediately after surgery and stimulates the regrowth of a new ACL (regenerative tissue engineering approach).
Thus, the surgical procedure is shortened and simplified, as it is reduced to a one-step procedure, and the extraction of autologous tissue is unnecessary, resulting in no loss of stability in other body regions.
Furthermore, RegACL implants are available in unlimited quantities (unlike the autologous materials), and can be implanted with all standard surgical procedures used today.
The silk-based RegACL acts as a lead structure for the regeneration of a body’s own ACL. Simultaneously with the cellular growth along the silk’s structure and the formation of the new natural ACL, the silk implant undergoes biological degradation over some months to a few years, so that the patient finally has a fully restored ACL.